Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00815685 · ClinicalTrials.gov registry record · NA
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00815685 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 36 participants.
The verdict
NCT00815685, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The data collected through this pilot study will allow us to increase our understanding of cancer cachexia and the effect of Eicosapentaenoic Acid (EPA) on cancer cachexia. Our long-term goal is to improve nutritional treatment and reduce illness in the cancer patient population.
Interventions
- DRUG Eicosapentaenoic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2007-07 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00815685
The ClinicalTrials.gov registry entry for NCT00815685 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Eicosapentaenoic Acid is the first listed.
NCT00815685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00815685 about?
NCT00815685 is a clinical study titled "A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia". The data collected through this pilot study will allow us to increase our understanding of cancer cachexia and the effect of Eicosapentaenoic Acid (EPA) on cancer cachexia. Our long-term goal is to improve nutritional treatment and reduce illness in the cancer patient population.
What is the current status of trial NCT00815685?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2007-07. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00815685?
The interventions under investigation include: Eicosapentaenoic Acid (DRUG).
Who is sponsoring clinical trial NCT00815685?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.